Stan Smith, Director at MAIA Biotechnology, Inc. (MAIA), bought 9,160 shares at $1.20 ($11K) on 2025-12-05, disclosed to the SEC on 2025-12-09.
Open-market purchase of $11k MAIA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.19 | 4,580 | $5K | 49.8% |
| 2 | $1.20 | 4,580 | $5K | 50.2% |
| Total | $1.20 avg | 9,160 | $11K | 100% |
| Filing → |
| MAIA | BUY | 2025-12-23 | $140K | — | Filing → |
| MAIA | BUY | 2025-12-01 | $16K | — | Filing → |
| MAIA | BUY | 2025-11-26 | $25K | — | Filing → |